These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 26345723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
    Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ.
    Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657
    [Abstract] [Full Text] [Related]

  • 4. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E, Cho W, Cha KH, Park J, Kim MS, Kim JS, Park HJ, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):91-8. PubMed ID: 20558265
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fabrication and evaluation of valsartan-polymer- surfactant composite nanoparticles by using the supercritical antisolvent process.
    Kim MS, Baek IH.
    Int J Nanomedicine; 2014 Aug 30; 9():5167-76. PubMed ID: 25404856
    [Abstract] [Full Text] [Related]

  • 8. Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability.
    Hong SW, Lee BS, Park SJ, Jeon HR, Moon KY, Kang MH, Park SH, Choi SU, Song WH, Lee J, Choi YW.
    Arch Pharm Res; 2011 Jan 30; 34(1):127-35. PubMed ID: 21468924
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
    Ha ES, Ok J, Noh J, Jeong HY, Choo GH, Jung YS, Baek IH, Kim JS, Cho W, Hwang SJ, Kim MS.
    Int J Biol Macromol; 2015 Jan 30; 72():1473-8. PubMed ID: 25451745
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability.
    Yang R, Li Y, Li J, Liu C, Du P, Zhang T.
    Drug Dev Ind Pharm; 2018 Feb 30; 44(2):289-295. PubMed ID: 29082762
    [Abstract] [Full Text] [Related]

  • 13. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L.
    Eur J Drug Metab Pharmacokinet; 2016 Aug 30; 41(4):413-22. PubMed ID: 25669445
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
    Rao Q, Qiu Z, Huang D, Lu T, Zhang ZJ, Luo D, Pan P, Zhang L, Liu Y, Guan S, Li Q.
    Eur J Pharm Sci; 2019 Feb 01; 128():222-231. PubMed ID: 30553058
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F, Kang A, Shan J, Zhao X, Bi X, Li J, Di L.
    Int J Pharm; 2014 Apr 25; 465(1-2):436-43. PubMed ID: 24576810
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.